Literature DB >> 20495216

The role of surgery and radiation therapy in the management of gestational trophoblastic disease.

Rabbie K Hanna1, John T Soper.   

Abstract

The primary management of hydatidiform moles remains surgical evacuation followed by human chorionic gonadotropin level monitoring. Although suction dilatation and evacuation is the most frequent technique for molar evacuation, hysterectomy is a viable option in older patients who do not wish to preserve fertility. Despite advances in chemotherapy regimens for treating malignant gestational trophoblastic neoplasia, hysterectomy and other extirpative procedures continue to play a role in the management of patients with both low-risk and high-risk gestational trophoblastic neoplasia. Primary hysterectomy can reduce the amount of chemotherapy required to treat low-risk disease, whereas surgical resections, including hysterectomy, pulmonary resections, and other extirpative procedures, can be invaluable for treating highly selected patients with persistent, drug-resistant disease. Radiation therapy is also often incorporated into the multimodality therapy of patients with high-risk metastatic disease. This review discusses the indications for and the role of surgical interventions during the management of women with hydatidiform moles and malignant gestational trophoblastic neoplasia and reviews the use of radiation therapy in the treatment of women with malignant gestational trophoblastic neoplasia.

Entities:  

Mesh:

Year:  2010        PMID: 20495216      PMCID: PMC3227996          DOI: 10.1634/theoncologist.2010-0065

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  58 in total

1.  Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma.

Authors:  R HERTZ; M C LI; D B SPENCER
Journal:  Proc Soc Exp Biol Med       Date:  1956-11

2.  Successful treatment of a patient with gestational trophoblastic neoplasm metastatic to the colon.

Authors:  F Ghaemmaghami; F Sohrabvand; H Ayatollahi; M Modarres
Journal:  J Obstet Gynaecol       Date:  2005-10       Impact factor: 1.246

3.  Selective vessel ligation in the pelvis: an invaluable tool in certain surgical procedures.

Authors:  K Sieunarine; P Moxey; D C M Boyle; L Ungar; I Lindsay; G Del Priore; J R Smith
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

Review 4.  Gestational trophoblastic disease.

Authors:  John T Soper
Journal:  Obstet Gynecol       Date:  2006-07       Impact factor: 7.661

5.  The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey.

Authors:  Nienke E van Trommel; Leon F A G Massuger; René H M Verheijen; Fred C G J Sweep; Chris M G Thomas
Journal:  Gynecol Oncol       Date:  2005-10       Impact factor: 5.482

6.  Reduced systemic toxicity from superselective chemoembolization compared with systemic chemotherapy in patients with high-risk metastatic gestational trophoblastic disease.

Authors:  E K Lang
Journal:  Cardiovasc Intervent Radiol       Date:  1997 Jul-Aug       Impact factor: 2.740

7.  High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.

Authors:  J T Soper; M Spillman; J H Sampson; J P Kirkpatrick; J K Wolf; D L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  2006-11-29       Impact factor: 5.482

8.  The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.

Authors:  M Pezeshki; B W Hancock; P Silcocks; J E Everard; J Coleman; A M Gillespie; J Tidy; R E Coleman
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

9.  Gestational trophoblastic disease metastatic to the central nervous system.

Authors:  A C Evans; J T Soper; D L Clarke-Pearson; A Berchuck; G C Rodriguez; C B Hammond
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

10.  Salvage surgery for chemorefractory gestational trophoblastic disease.

Authors:  E Lehman; D M Gershenson; T W Burke; C Levenback; E G Silva; M Morris
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

View more
  7 in total

1.  Colon cancer chemopreventive effects of baicalein, an active enteric microbiome metabolite from baicalin.

Authors:  Chong-Zhi Wang; Chun-Feng Zhang; Lina Chen; Samantha Anderson; Fang Lu; Chun-Su Yuan
Journal:  Int J Oncol       Date:  2015-09-18       Impact factor: 5.650

2.  SEOM clinical guidelines in gestational trophoblastic disease (2017).

Authors:  A Santaballa; Y García; A Herrero; N Laínez; J Fuentes; A De Juan; V Rodriguez Freixinós; J Aparicio; A Casado; E García-Martinez
Journal:  Clin Transl Oncol       Date:  2017-11-17       Impact factor: 3.405

Review 3.  [Progress of the diagnosis and treatment of pulmonary metastasis of gestational choriocarcinoma].

Authors:  Dongjie Ma; Zhiyong Zhang; Shanqing Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-10

4.  The role of pulmonary resection in the management of metastatic gestational trophoblastic neoplasia: Two cases of durable remission following surgery for chemo-resistant disease.

Authors:  Jeanine N Staples; Sarah Podwika; Linda Duska
Journal:  Gynecol Oncol Rep       Date:  2019-09-06

Review 5.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

6.  Thoracotomy in refractory gestational trophoblastic neoplasia with lung metastasis after normalization of serum beta human chorionic gonadotropin (β-hCG) with salvage chemotherapy.

Authors:  Fengzhi Feng; Huiying Hu; Lei Wu; Tong Ren; Xirun Wan; Yang Xiang
Journal:  Onco Targets Ther       Date:  2014-01-29       Impact factor: 4.147

7.  Thoracoscopic Surgery to Treat Lung Metastases from Refractory Choriocarcinoma.

Authors:  Luo Zhao; Yingzhi Qin; Dongjie Ma; Li Li; Zhijun Han; Shanqing Li; Hongsheng Liu
Journal:  Cancer Manag Res       Date:  2020-05-25       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.